In vitro, cytosolic human ketone reductases catalyse the stereospecifi
c (i.e. >99%) formation of S(-) reduced haloperidol (RHP) from haloper
idol (HP). Whether this situation is reflected in patients taking the
drug is unknown. In this study in nine patients taking HP, only 73.2+/
-18.2% of the RHP excreted in urine was the S(-) enantiomer. Thus, enz
ymes other than cytosolic ketone reductases must be responsible for th
e formation of the minor enantiomer. (C) 1998 Elsevier Science B.V./EC
NP.